---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003632"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T10:59:26.595816+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma director James Scibetta resigns from board effective Jan 21, 2025

## Summary
- James S. Scibetta resigned from the Board of Directors effective January 21, 2025.
- He also resigned from his positions on the Audit and Compensation Committees.
- Resignation was due to other professional obligations, not a material disagreement.
- No replacement director has been announced at this time.

## SEC filing metadata
- accession: 0001493152-25-003632
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315225003632/0001493152-25-003632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315225003632/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003632
- JSON: https://secwatch.observer/filing/0001493152-25-003632.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.